SOFIA DE LA CAMARA: Open Payments
NPI 1023572153 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,843 in 55 payments from 14 companies in 2025. Trend: 2023 $861 · 2024 $525 · 2025 $1,843
Food & beverage: $1,843
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $367 |
| Incyte Corporation | 14 | $351 |
| ABBVIE INC. | 8 | $300 |
| GENZYME CORPORATION | 8 | $178 |
| PFIZER INC. | 9 | $163 |
| UCB, Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $117 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52 |
| Cipher Pharmaceuticals US LLC | 1 | $28 |
Products named: NEMLUVIO, OPZELURA, RINVOQ, DUPIXENT, CIBINQO, Bimzelx, Winlevi, Natroba.
Industry payments across FL — which companies pay providers there.
